Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products... Show more
Cabot Corporation operates at the intersection of mature industrial supply chains and high-growth technology markets. The Reinforcement Materials segment, which contributes roughly 65% of revenue and supplies reinforcing carbons essential to tire and industrial rubber manufacturing, benefits from deep customer relationships, global manufacturing scale across 39 facilities, and high barriers to entry driven by stringent environmental regulations. However, this segment is navigating a structurally more competitive landscape. Indian carbon black producers are gaining share in Western markets following reduced trade barriers, while Asian tire imports continue to displace domestic production in North America and Europe, compressing utilization rates below 80% in the Americas.
The Performance Chemicals segment tells a more compelling medium-term story. Within it, the Battery Materials product line has emerged as a strategic growth engine, recording a 43% year-over-year revenue increase in the second quarter of fiscal 2026. The January 2026 supply agreement with PowerCo SE—Volkswagen Group's dedicated battery manufacturing subsidiary—validates Cabot's technology and positions the company as a credible Tier 1 conductive materials supplier to the European EV ecosystem. Additionally, Cabot's portfolio of fumed silica, aerogel, and specialty carbons serves secular growth markets including grid infrastructure, renewable energy, and advanced electronics, providing diversification beyond the tire cycle.
The company's "Creating for Tomorrow" strategy—built on the pillars of Grow, Innovate, and Optimize—reflects a deliberate pivot toward higher-margin, innovation-driven applications while simultaneously rationalizing legacy capacity. The $70 million acquisition of Bridgestone's reinforcing carbons plant in Mexico, completed in late 2025, exemplifies management's disciplined approach to M&A (mergers and acquisitions): strengthen competitive positioning, enhance geographic access, and generate attractive economic returns within a three-to-five-year horizon.
Several events and developments stand to shape investor sentiment around CBT over the coming quarters. The most immediate is the fiscal third-quarter 2026 earnings release, scheduled for August 3, 2026. Consensus estimates point to EPS of approximately $1.62 on revenue of $911 million, with analysts watching closely for updated commentary on Reinforcement Materials pricing dynamics, Battery Materials order momentum, and progress on the cost-rationalization program.
Beyond quarterly results, the ramp-up of the PowerCo supply agreement represents a critical operational milestone. As Cabot scales production of its conductive carbons and dispersions for lithium-ion battery electrodes, investors will assess whether Battery Materials can grow its EBITDA contribution—currently estimated at roughly $34 million—to a level that meaningfully offsets cyclical pressure in Reinforcement Materials. The company's capacity rationalization initiative in South America and Europe is another key catalyst; successful execution could unlock approximately $22 million in annual fixed-cost savings and signal management's willingness to proactively resize the cost base.
On the analyst front, sentiment has been cautiously improving. Mizuho raised its price target to $90 while maintaining a Neutral rating in late June 2026, and UBS lifted its target to $97 in July 2026. JP Morgan remains the most bearish voice with an Underweight rating and $70 target. The consensus rating across active analysts currently stands at a cautious "Hold" equivalent, with an average price target of approximately $82–$90 depending on the data source, suggesting limited consensus upside conviction despite improving individual estimates. Any further upgrades or target revisions following the August earnings release could serve as a sentiment catalyst.
Other potential catalysts include additional battery materials supply agreements, strategic M&A in high-growth adjacencies, and further expansion of the EVOLVE Sustainable Solutions platform. The company now operates 14 ISCC PLUS certified sites globally, and as tire manufacturers accelerate toward 40% sustainable material content targets by 2030, demand for certified circular reinforcing carbons could inflect higher.
Cabot's trajectory is tightly linked to the health of global manufacturing and automotive end markets. European manufacturing PMI has remained below the 50 threshold—indicating contraction—for three consecutive years, while North American light-vehicle production is experiencing its third straight year of decline. These macro headwinds directly suppress demand for reinforcing carbons, which are primarily consumed in tire production and industrial rubber goods.
Trade policy remains a critical variable. Reduced tariffs on Indian carbon black imports have intensified competitive intensity in Western markets, contributing to the anticipated 7–9% pricing reset. Meanwhile, broader U.S. tariff policy—including the Section 232 tariffs on steel and aluminum and their derivative effects on automotive supply chains—introduces uncertainty around customer ordering patterns and regional trade flows. On the positive side, the EU's decision to remove remaining tariffs on many U.S. industrial goods through 2029 provides a more stable export framework for Cabot's European-facing business.
Interest rates and inflation trends also matter. Lower rates could eventually stimulate housing and industrial activity, benefiting chemical end-markets, while sustained inflation in raw materials and energy costs could pressure margins if pricing power proves insufficient. Approximately 80% of Cabot's revenue is generated outside the United States, making currency fluctuations another important variable for dollar-denominated investors.
The energy transition is a powerful structural tailwind. Electrification of transport and the build-out of grid-scale battery energy storage systems are driving secular demand growth for conductive carbon additives, carbon nanotubes (CNTs), and fumed metal oxides—all areas where Cabot holds meaningful technological capabilities and production capacity. This megatrend provides a long-term growth narrative that partially insulates the stock from near-term cyclical weakness in traditional chemical markets.
Investors seeking to anticipate directional moves in CBT and thousands of other tradable assets may find value in Tickeron's Trend Prediction Engine. This AI-powered forecasting tool analyzes market data to identify whether a stock, ETF (exchange-traded fund), or other instrument may trend bullish, bearish, or sideways over the coming week or month. Designed to help traders spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a broad universe of instruments, the Trend Prediction Engine includes searchable prediction categories, historical context, and alert-oriented functionality for those who want to stay ahead of evolving market conditions. Exploring its insights may complement traditional fundamental analysis when assessing names like Cabot Corporation.
Looking into the second half of 2026 and beyond, Cabot's investment narrative hinges on whether the growth trajectory in Battery Materials and Performance Chemicals can outrun the structural headwinds in Reinforcement Materials. Consensus estimates project fiscal 2027 EPS of approximately $6.93–$7.00, implying a roughly 10–11% year-over-year recovery from the fiscal 2026 midpoint, with revenue expected to grow modestly to approximately $3.68–$3.72 billion.
Several long-term themes merit close attention. Battery materials scale-up is the most visible growth vector: if the PowerCo partnership performs as anticipated and additional OEM (original equipment manufacturer) agreements materialize, Battery Materials could evolve from a ~$34 million EBITDA contributor into a more substantial earnings pillar by decade's end. Sustainability-driven demand for circular reinforcing carbons under the EVOLVE platform could also reshape the revenue mix, particularly as tire manufacturers accelerate toward their 2030 sustainable-material targets.
Capital allocation will remain a defining feature. Management has demonstrated a balanced approach—investing in high-confidence growth projects, maintaining a competitive dividend (recently increased by 5%), repurchasing shares ($100–$200 million expected in fiscal 2026), and pursuing disciplined M&A. The company's strong balance sheet, with net debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) of approximately 1.2x exiting fiscal 2025, provides ample flexibility to fund strategic priorities even during earnings troughs.
Key risks to the long-term outlook include further erosion of Reinforcement Materials pricing power if Asian competition intensifies beyond current expectations, a prolonged downturn in global auto production, and execution risk associated with battery materials scale-up. Conversely, faster-than-anticipated EV adoption in Europe, successful commercialization of next-generation conductive additives, and potential geopolitical normalization in Eastern Europe could all provide upside catalysts not currently reflected in the cautious consensus analyst stance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a supplier of organic chemicals
Industry ChemicalsSpecialty
A.I.dvisor indicates that over the last year, CBT has been loosely correlated with ASIX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CBT jumps, then ASIX could also see price increases.
| Ticker / NAME | Correlation To CBT | 1D Price Change % | ||
|---|---|---|---|---|
| CBT | 100% | -0.03% | ||
| ASIX - CBT | 62% Loosely correlated | +4.49% | ||
| OLN - CBT | 61% Loosely correlated | +1.82% | ||
| AVNT - CBT | 57% Loosely correlated | +1.74% | ||
| HUN - CBT | 55% Loosely correlated | +1.67% | ||
| DOW - CBT | 55% Loosely correlated | -0.69% | ||
More | ||||
CBT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where CBT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on August 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBT as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
CBT moved below its 50-day moving average on August 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CBT crossed bearishly below the 50-day moving average on August 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CBT advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .
CBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.775) is normal, around the industry mean (7.157). P/E Ratio (24.165) is within average values for comparable stocks, (38.999). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.421). Dividend Yield (0.021) settles around the average of (0.019) among similar stocks. P/S Ratio (1.251) is also within normal values, averaging (99.070).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CBT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.